Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Submitted by
admin
on May 17, 2013 - 10:43am
Source:
Yahoo/Reuters
News Tags:
Galapagos
AbbVie
GLPG0634
Crohn's Disease
Headline:
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Do Not Allow Advertisers to Use My Personal information
